Tilray Inc (NASDAQ: TLRY) stock price is trading over 20% ahead of IPO as of 6:13 a.m. ET This appears to be a continuation of the momentum from corporate news announced yesterday

Yesterday, Tilray announced that it has entered into an agreement with Grow Pharma to import and distribute Tilray medical cannabis products to the UK and this agreement enables Tilray to provide locally serviced medical cannabis solutions to authorized UK patients in need to ask

Tilray expects a range of GMP certified medical cannabis products to be available to patients in the UK by March 2021, and patients wishing to consume medicinal cannabis will have access to Tilray products in the UK by obtaining prescriptions through a private practice or Get the National Health Service (NHS)

Disclaimer: This content is provided for informational purposes before making any investment, it is recommended that you do your own analysis

TLRY share

World News – USA – TLRY share price rises by over 20% before market entry: Why it happened

Source: https://pulse2.com/tlry-stock-price-nasdaq-tilray-increases-over-20-pre-market-why-it-happened-2/